Improve Medical Instruments Co., Ltd. (SHE:300030)
China flag China · Delayed Price · Currency is CNY
6.85
+0.11 (1.63%)
Aug 25, 2026, 10:05 AM CST

SHE:300030 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
30.4214.53-117.9-63.2-198.318.57
Depreciation & Amortization
32.2933.9639.8545.1346.7553.31
Other Amortization
1.871.982.033.582.672.63
Loss (Gain) From Sale of Assets
-3.11-2.09-0.9-6.45-0.44-0.02
Asset Writedown & Restructuring Costs
19.2422.623.338.9990.081.39
Loss (Gain) From Sale of Investments
-0.36-10.3163.56-7.4453.1-19.34
Provision & Write-off of Bad Debts
-5.28-5.2823.96-3.089.17.75
Other Operating Activities
15.9717.2534.5247.9253.4744.18
Change in Accounts Receivable
155.53141.9219.652.76-12.59109.82
Change in Inventory
-5.489.12-0.09-19.77-16.14-15.78
Change in Accounts Payable
-94.74-117.32-1.926.9738.21-32.99
Operating Cash Flow
149.55109.981.8479.942.48171.74
Operating Cash Flow Growth
83.01%34.29%2.42%88.11%-75.27%21.56%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-26.89-24.12-51.28-43.7-58.04-71.05
Sale of Property, Plant & Equipment
1.121.5837.513.60.060.13
Divestitures
----26.62.71
Investment in Securities
-128.35-20-13.255.79
Other Investing Activities
33.0626.52-1.0821.59-22.62
Investing Cash Flow
7.294.9813.5-38.5-44.64-39.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-231.4354.73393.58381.99272.62
Long-Term Debt Repaid
--425.99-405.57-425.18-467.2-250.39
Net Debt Issued (Repaid)
-136.72-194.59-50.84-31.6-85.2122.24
Issuance of Common Stock
--0.03--9.91
Common Dividends Paid
-3.74-5.5-11.97-15.94-37.67-31.14
Other Financing Activities
-8.14-3.232.14-2.562.05-3.57
Financing Cash Flow
-148.6-203.32-60.63-50.09-120.83-2.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.90.321.230.610.98-0.88
Net Cash Flow
7.33-88.1335.94-8.08-122.01128.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
122.6685.7730.5536.2-15.56100.69
Free Cash Flow Growth
149.35%180.72%-15.60%--19.22%
Free Cash Flow Margin
26.07%17.64%5.26%5.62%-2.19%12.59%
Free Cash Flow Per Share
0.420.290.100.12-0.050.33
Levered Free Cash Flow
100.7681.5753.0111.4-9.7842.7
Unlevered Free Cash Flow
103.9884.7859.9421.762.5358.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
21.1323.7626.2122.4830.0347.81
Change in Working Capital
58.5237.2613.454.48-13.9463.26